Researchers from Johns Hopkins and Northwestern universities have
discovered how to control the shape of nanoparticles that move DNA through the
body and have shown that the shapes of these carriers may make a big difference
in how well they work in treating cancer and other diseases.
This study, to be published in the Oct. 12 online edition of the
journal Advanced Materials, is also noteworthy because this gene therapy
technique does not use a virus to carry DNA into cells. Some gene therapy
efforts that rely on viruses have posed health risks.
"These nanoparticles could become a safer and more effective
delivery vehicle for gene therapy, targeting genetic diseases, cancer and other
illnesses that can be treated with gene medicine," said Hai-Quan Mao, an
associate professor of materials science and engineering in Johns Hopkins' Whiting
School of Engineering.
Mao, co-corresponding author of the Advanced Materials article,
has been developing non-viral nanoparticles for gene therapy for a decade. His
approach involves compressing healthy snippets of DNA within protective polymer
coatings. The particles are designed to deliver their genetic payload only
after they have moved through the bloodstream and entered the target cells.
Within the cells, the polymer degrades and releases DNA. Using this DNA as a
template, the cells can produce functional proteins that combat disease.
A major advance in this work is that Mao and his colleagues
reported that they were able to "tune" these particles in three
shapes, resembling rods, worms and spheres, which mimic the shapes and sizes of
viral particles. "We could observe these shapes in the lab, but we did not
fully understand why they assumed these shapes and how to control the process
well," Mao said. These questions were important because the DNA delivery
system he envisions may require specific, uniform shapes.
To solve this problem, Mao sought help about three years ago from
colleagues at Northwestern. While Mao works in a traditional wet lab, the
Northwestern researchers are experts in conducting similar experiments with
powerful computer models.
Erik Luijten, associate professor of materials science and
engineering and of applied mathematics at Northwestern's McCormick School of
Engineering and Applied Science and co-corresponding author of the paper, led
the computational analysis of the findings to determine why the nanoparticles
formed into different shapes.
"Our computer simulations and theoretical model have provided
a mechanistic understanding, identifying what is responsible for this shape
change," Luijten said. "We now can predict precisely how to choose
the nanoparticle components if one wants to obtain a certain shape."
The use of computer models allowed Luijten's team to mimic
traditional lab experiments at a far faster pace. These molecular dynamic
simulations were performed on Quest, Northwestern's high-performance computing
system. The computations were so complex that some of them required 96 computer
processors working simultaneously for one month.
In their paper, the researchers also wanted to show the importance
of particle shapes in delivering gene therapy. Team members conducted animal
tests, all using the same particle materials and the same DNA. The only
difference was in the shape of the particles: rods, worms and spheres.
"The worm-shaped particles resulted in 1,600 times more gene
expression in the liver cells than the other shapes," Mao said. "This
means that producing nanoparticles in this particular shape could be the more
efficient way to deliver gene therapy to these cells."
The particle shapes used in this research are formed by packaging
the DNA with polymers and exposing them to various dilutions of an organic
solvent. DNA's aversion to the solvent, with the help of the team's designed
polymer, causes the nanoparticles to contract into a certain shape with a
"shield" around the genetic material to protect it from being cleared
by immune cells.
Lead authors of the Advanced Materials paper are
Wei Qu, a graduate student in Luijten's research group at Northwestern, and
Xuan Jiang, who was a doctoral student in Mao's lab. Along with Mao and
Luijten, the remaining co-authors of the paper, all from Johns Hopkins, are
Deng Pan, who worked on the project as an undergraduate; Yong Ren, a
postdoctoral fellow; John-Michael Williford, a biomedical engineering doctoral
student; and Honggang Cui, an assistant professor in the department of chemical
and biomolecular engineering.
Journal Reference:
1. Xuan Jiang, Wei Qu, Deng Pan, Yong Ren,
John-Michael Williford, Honggang Cui, Erik Luijten, Hai-Quan Mao.Plasmid-Templated
Shape Control of Condensed DNA-Block Copolymer Nanoparticles. Advanced
Materials, 2012; DOI: 10.1002/adma.201202932
0 comments:
Post a Comment